Medical Devices

ENNOVI's Tijuana expansion offers a key nearshoring solution for medical device makers, tackling complex regulations and streamlining North American supply chains.

A Norwegian firm's new AI software aims to reduce physician distractions and build trust, setting a new standard for cancer-detecting technology.

China approves Libevitug, a first-in-class drug for the most severe form of hepatitis, marking a major milestone for patients and global biotech innovation.

With drug pipelines facing staggering failure rates, HKeyBio's new preclinical strategy aims to de-risk R&D and accelerate effective new treatments.

A strategic investment from Krieger Capital will fuel Global Key Solutions' AI platform, which transforms complex regulatory data into actionable safety insights.

Fresh analyst coverage signals a potential rebirth for the med-tech firm after a major financial restructuring. But why do experts disagree on its value?

With cardiac arrest striking every 9 minutes, a Québec foundation calls for a new law, citing a 29,000-defibrillator gap to ensure survival isn't left to chance.

A new report details a dramatic rise in ransomware and supply chain attacks, turning digital threats into life-or-death crises for the global health sector.

A new study reveals albumin, the most abundant protein in blood, is a powerful weapon against mucormycosis, offering new hope for treating this fatal infection.

Myra Vision's Calibreye system, the first adjustable glaucoma shunt, has been implanted in a US patient, offering hope for personalized vision-saving therapy.

The acquisition strengthens the independent distributor's hold on the booming plasma therapy market, promising wider access to critical, complex medications.

A new study confirms AI can detect major heart conditions from one brief ultrasound clip, empowering any clinician to perform life-saving cardiac screening.

Avant Technologies is evaluating a therapy to protect insulin cells from immune attack, a breakthrough that could end the need for harsh drugs.

Baird Medical partners with Stonewood Key Capital, using China's Hainan Free Trade Port to accelerate its global push for minimally invasive therapies.

A first-in-class oral therapy targeting cellular metabolism has entered patient trials, offering new hope for a disease-modifying treatment for eczema.

A new intelligent oral appliance using biofeedback shows a massive reduction in sleep bruxism, offering hope to millions who suffer from jaw pain and headaches.

Medical device maker Nuwellis appoints two new directors and sees three resign, a move tied directly to a critical upcoming $5 million equity investment.

With a year of consistent earnings beats and strategic product launches behind it, Enovis is set to reveal its full 2025 results. Here’s what’s at stake.

New 24-month clinical data shows Nalu's tiny neurostimulator provides sustained pain relief and improved function, setting a new bar for chronic pain tech.

Acrivon Therapeutics to unveil pivotal data showing high response rates for its targeted drug ACR-368 in an aggressive endometrial cancer subtype.